缅北禁地

Roles and Responsibilities

• Management of 缅北禁地 Cancer Centre Pharmacology Group (NCCPG)
• Executive Board (缅北禁地 Centre for Cancer)
• Lead on early phase clinical trials (PK/PD) in adult and childhood cancers
• Coordination of national paediatric clinical pharmacology studies
• Supervision of undergraduate, MRes and PhD student projects
• Teaching (BSc Pharmacology; MPharm Pharmacy; MRes Medical and Molecular Biosciences)

Areas of expertise

• Clinical pharmacology studies in oncology

Qualifications

• BSc Pharmacology (Hons), University of Liverpool
• Ph.D. (Clinical Pharmacology), University of Liverpool

Previous Positions

• 2010 to 2018 - Senior Lecturer, Northern Institute for Cancer Research, 缅北禁地.
• 2005 to 2010 - Academic Fellow, Northern Institute for Cancer Research, 缅北禁地.
• 2001 to 2005 - Senior Research Associate, Northern Institute for Cancer Research, 缅北禁地.
• 1998 to 2001 - Postdoctoral Research Associate, Cancer Research Unit, 缅北禁地.
• 1996 to 1998 - Postdoctoral Fellow, Division of Experimental Medicine and Haematology/Oncology, Harvard Medical School.

Memberships

Member of the following organisations :-

• Sarcoma UK Research Strategy Committee
• Great Ormond Street Hospital Charity External Grants Review Panel
• Children's Brain Tumour Drug Delivery Consortium (CBTDDC) Steering Group
• Children’s Cancer and Leukaemia Group (CCLG) (Pharmacology Subcommittee Chair)
• International Society of Paediatric Oncology (SIOP) Scientific Programme Advisory Working Group
• Experimental Cancer Medicine Centres (ECMC) Paediatric Strategy Group
• EMA European Network of Paediatric Research (Enpr-EMA) Scientific Committee
• NCRI Children's Cancer and Leukaemia CSG Novel Agents Subgroup
• International Association of Therapeutic Drug Monitoring and Clinical Toxicology 
• British Pharmacological Society Clinical Committee
• British Association for Cancer Research (BACR)
• American Association for Cancer Research (AACR)
• European Association for Cancer Research (EACR) 

Honours and Awards

Awards/achievements :-

• Winner of the Children's Cancer and Leukaemia Group (CCLG) Innovation in Practice Award 2022 (April, 2022)
• Bright Ideas in Health Awards 2018 - Service Improvement Category Finalist (November, 2018)
• British Pharmacological Society (BPS) Clinical Oral Communication Award (December, 2016)
• Winner of the Quality in Care (QiC) Excellence in Oncology 'Best Innovation in Service Provision - Partnership Across the Pathway' Award for the establishment of a national therapeutic drug monitoring service for the treatment of children with cancer (December, 2013)
• BACR Mid-Career Fellowship (£2,000) – awarded to support a collaborative visit to the Tata Memorial Hospital, India (October, 2010)
• AACR-Merck Scholar-in-Training Award ($1,400) – received at the 100th Annual Meeting of the American Association of Cancer Research, Denver (April, 2009)
• AACR-GlaxoSmithKline Outstanding Clinical Scholar Award ($4,000) – received at the 95th Annual Meeting of the American Association of Cancer Research, Orlando (April, 2004)
• BACR Exchange Fellowship (£1,500) – received to support research carried out in laboratory of Dr. David Waxman, Boston University, USA (June – August, 2004)

Google Scholar:

SCOPUS:

Research Interests

I lead an enthusiastic and experienced research team based in the university Paul O'Gorman building (/cancer/our-research/drug-discovery-and-pre-clinical-development/pharmacology/). Our research involves the design and coordination of clinical pharmacology studies involving both adults and children with cancer. These studies are associated with a wide range of approaches to cancer treatment including the development of novel agents, early phase clinical trials, the optimisation of established therapeutics and individualisation/personalisation of patient treatment. Studies are carried out at a national and European level involving the treatment of patients at centres throughout the UK and Europe. In addition to these clinical studies, I am involved in laboratory-based molecular and pharmacological translational research projects.

Other Expertise

Other research interests/expertise include the following :-

- biomarker studies

- therapeutic drug monitoring

- pharmacogenetic studies

- clinical welfare of children involved in research studies

Funding

Cancer Research UK

NIHR Research for Patient Benefit

NIHR Invention for Innovation (i4i)

UK Research and Innovation (Innovate UK)

Little Princess Trust

Bone Cancer Research Trust

European Commission Horizon 2020

Wellcome Trust Health Innovation Challenge Fund

Children with Cancer UK

European Commission Seventh Framework Programme (FP7)

Medical Research Council DPFS

Medical Research Council DTA

Research Councils UK

Sarcoma UK

Sparks Children's Medical Research Charity

缅北禁地 Hospitals Special Trustees

Esteem Indicators

Editorial board member for European Journal of Cancer: Paediatric Oncology, Cancers, Pharmacology Research & Perspectives, Cancer Chemotherapy and Pharmacology and Frontiers in Oncology  

Reviewer for the following journals :-

- Journal of Clinical Oncology

- Clinical Cancer Research

- Molecular Cancer Therapeutics

- British Journal of Cancer

- European Journal of Cancer

- Cancer Chemotherapy and Pharmacology

- Clinical Pharmacokinetics

- Therapeutic Drug Monitoring

- Pediatric Blood and Cancer

- British Journal of Pharmacology

- Expert Opinion on Drug Delivery

- Pediatric Hematology and Oncology

- BMC Cancer

- Frontiers in Oncology

- Journal of Pediatric Hematology/Oncology

- British Journal of Clinical Oncology

- Journal of Pharmaceutical and Biomedical Analysis

- British Journal of Urology International

Undergraduate Teaching

BSc (Hons) Pharmacology

PED2001: Drug disposition and pharmacokinetics

PED3006: Carcinogenesis and anticancer drugs

Pharmacy MPharm Honours

PHAR2006: Pharmaceutical Care - pathology, patients and professionalism

Postgraduate Teaching

MRes in Medical and Molecular Biosciences (MMS8007: Cancer Studies)

MSc Medical Sciences (MMS8101: Research Practice in the 21st Century; MMS8107: Cancer Studies)

• Articles

  • Kelk J, Rozanska A, Sotiriadou E, Astley D, Hussain R, Unsworth A, Gangar A, Robinson A, Queen R, Coxhead J, Steel DH, Armstrong L, Parulekar M, Hardcastle I, Veal GJ, Lako M. . Molecular Therapy - Oncology 2026, 34(1), 201160.
  • Vormoor B, Savage J, Kristunas C, Johnson S, Blanco MNF, Shenton G, Lancaster D, Castleton A, Fielding AK, Latif A-L, Morley N, Strullu M, Tuckuviene R, Kearns P, Jennings C, Barnett S, Veal GJ, Irving J, Billingham L, Menne T, Vormoor J. . EJC Paediatric Oncology 2026, 7, 100489.
  • Brandon AM, Huisman-Siebinga H, Barnett S, Wetherell P, Keans P, Gibson B, Heaney N, Smith O, Baruchel A, Petit A, Moore A, Ogungbenro K, Huitema ADR, Veal GJ. . British Journal of Clinical Pharmacology 2026, epub ahead of print.
  • Whitaker D, Francis F, Karaborni S, Smith S, Craigen JL, Svetlik S, Barnett S, Veal GJ. . Bioanalysis 2025, 17(17), 1105-1112.
  • Gulati P, Carruthers V, Hutton C, Cassidy C, Amankwatia EB, Pascual S, Florence E, Gebru TG, Jorgensen AL, Greystoke A, Makin G, McCabe MG, Hawcutt DB, Veal GJ, Jamieson D. . EJC Paediatric Oncology 2025, 5, 100216.
  • Millen GC, Lawford A, Duncan C, Jenkinson H, Veal GJ, Barnett S. . British Journal of Cancer 2024, 131, 491-497.
  • Serra R, Smith SJ, Rowlinson J, Gorelick N, Moloney C, McCrorie P, Veal GJ, Berry P, Chalmers AJ, Suk I, Shakesheff KM, Alexander C, Grundy RG, Brem H, Tyler BM, Rahman R. . British Journal of Cancer 2024, 131, 1858-1868.
  • Bell HL, Blair HJ, Jepson Gosling SJ, Galler M, Astley D, Moorman AV, Heidenreich O, Veal GJ, van Delft FW, Lunec J, Irving JAE. . Leukemia 2024, 38, 1223-1235.
  • Mohmaed Ali MI, Nijstad AL, Boosman RJ, Crombag M-RBS, Barnett S, Veal GJ, Lalmohamed A, van Erp NP, Steeghs N, Zwaan CM, Beijnen JH, Siebinga H, Huitema ADR. . Clinical Pharmacokinetics 2024, 63, 1711-1722.
  • Spiliopoulou P, Kazmi F, Aroldi F, Holmes T, Thompson D, Griffiths L, Qi C, Parkes M, Lord S, Veal GJ, Harrison DJ, Coyle VM, Graham J, Evans TRJ, Blagden SP. . Journal of Experimental and Clinical Cancer Research 2024, 43(1), 100.
  • Spicer J, Basu B, Montes A, Banerji U, Kristeleit R, Miller R, Veal GJ, Corrigan CJ, Till SJ, Figini M, Canevari S, Barton C, Jones P, Mellor S, Carroll S, Selkirk C, Nintos G, Kwatra V, Funingana I-G, Doherty G, Gould HJ, Pellizzari G, Nakamura M, Ilieva KM, Khiabany A, Stavraka C, Chauhan J, Gillett C, Pinder S, Bax HJ, Josephs DH, Karagiannis SN. . Nature Communications 2023, 14(1), 4180.
  • Damoiseaux D, Amant F, Beijnen JH, Barnett S, Veal GJ, Huitema ADR, Dorlo TPC. . CPT: Pharmacometrics and Systems Pharmacology 2023, 12(12), 1931-1944.
  • Barnett S, Makin G, Tweddle DA, Osborne C, Veal GJ. . British Journal of Cancer 2023, 129, 1773–1779.
  • Barnett S, Nyein AC, Galler M, Jamieson D, Davies M, Connor P, Veal GJ. . Cancer Chemotherapy and Pharmacology 2023, 92, 325–328.
  • Halford S, Veal GJ, Wedge SR, Payne GS, Bacon CM, Sloan P, Dragoni I, Heinzmann K, Potter S, Salisbury BM, Chenard-Poirier M, Greystoke A, Howell EC, Innes WA, Morris K, Plummer C, Rata M, Petrides G, Keun HC, Banerji U, Plummer R. . Clinical Cancer Research 2023, 29(8), 1429-1439.
  • Lopez J, Lai-Kwon J, Molife R, Welsh L, Tunariu N, Roda D, Fernandez-Garcia P, Lladó V, McNicholl A, Roselló C, Taylor R, Azaro A, Ahnert JR, Sludden J, Veal G, Plummer R, Urruticoechea A, Lahuerta A, Mujika K, Escriba P. . British Journal of Cancer 2023, 129, 811-818.
  • Kristeleit R, Plummer R, Jones R, Carter L, Blagden S, Sarker D, Arkenau T, Evans TRJ, Danson S, Symeonides SN, Veal GJ, Klencke BJ, Kowalski MM, Banerji U. . British Journal of Cancer 2023, 129, 38-45.
  • Barnett S, Hellman F, Parke E, Makin G, Tweddle DA, Osborne C, Hempel G, Veal GJ. . European Journal of Cancer 2022, 164, 127-136.
  • Menne T, Slade D, Savage J, Johnson S, Irving J, Kearns P, Plummer R, Shenton G, Veal GJ, Vormoor B, Vormoor J, Billingham L. . BMJ Open 2022, 12, e059872.
  • Apps JR, Maycock S, Ellison DW, Jaspan T, Ritzmann TA, Macarthur D, Malluci C, Wheatley K, Veal GJ, Grundy RG, Picton S. . Neuro-Oncology Advances 2022, 4(1), 1-11.
  • Idowu OS, Craigen JL, Veal GJ, Jamieson D. . Bioanalysis 2022, 14(18), 1241-1249.
  • Carruthers V, Barnett S, Rees R, Arif T, Slater O, Ramanujachar R, Johnson K, Brown S, Graham C, Burke GAA, Veal GJ. . Pediatric Blood and Cancer 2022, 69(7), e29722.
  • Nijstad AL, Chu W-Y, de Vos-Kerkhof E, Enters-Weijnen CF, van de Velde ME, Kaspers GJL, Barnett S, Veal GJ, Lalmohamed A, Zwaan CM, Huitema ADR. . Pharmaceutical Research 2022, 39, 2487-2495.
  • Veal GJ, Tweddle DA, Visser J, Errington J, Buck H, Marange J, Moss J, Joseph S, Mulla H. . Cancers 2021, 13(8), 1868.
  • Barnett S, Errington J, Sludden J, Jamieson D, Poinsignon V, Paci A, Veal GJ. . Pharmaceuticals 2021, 14(3), 272.
  • Gowland C, Berry P, Errington J, Jeffrey P, Bennett G, Godfrey L, Pittman M, Niewiarowski A, Symeonides SN, Veal GJ. . Bioanalysis 2021, 13(2), 101-113.
  • Gionfriddo I, Brunetti B, Mezzasoma F, Milano F, Cardinali V, Ranieri R, Venanzi A, Pierangeli S, Vetro C, Spinozzi G, Dorillo E, Wu H, Ciurnelli R, Griffin MJ, Jennings CE, Tiavvi E, Sportoletti E, Falzetti F, de The H, Veal GJ, Martelli MP, Falini B. . Leukemia 2021, 35, 2552–2562.
  • Roberts E, Mogg JAW, Barnfield M, Veal GJ. . Pediatric Hematology and Oncology 2020, 37(3), 235-244.
  • Hawley J, Veal GJ, Errington J, McDonald LG, Tweddle DA. . Pediatric Blood and Cancer 2019, 66(9), 1-3.
  • Chen L, Pastorino F, Berry P, Bonner J, Kirk C, Wood KM, Thomas HD, Zhao Y, Daga A, Veal GJ, Lunec J, Newell DR, Ponzoni M, Tweddle DA. . International Journal of Cancer 2019, 144(12), 3146-3159.
  • Duong JK, Veal GJ, Nath CE, Shaw PJ, Errington J, Ladenstein R, Boddy AV. . British Journal of Clinical Pharmacology 2019, 85(1), 136-146.
  • Lee CM, Zane NR, Veal G, Thakker DR. . CPT Pharmacometrics and Systems Pharmacology 2019, 8(10), 759-768.
  • Smith SJ, Tyler BM, Gould T, Veal GJ, Gorelick N, Rowlinson J, Serra R, Ritchie A, Berry P, Otto A, Choi J, Skuli N, Estevez-Cebrero M, Shakesheff KM, Brem H, Grundy RG, Rahman R. . Clinical Cancer Research 2019, 25(16), 5094-5106.
  • Jackson RK, Liebich M, Berry P, Errington J, Liu J, Parker C, Moppett J, Samarasinghe S, Hough R, Rowntree C, Goulden NJ, Vora A, Kearns PR, Saha V, Hempel G, Irving JAE, Veal GJ. . European Journal of Cancer 2019, 120, 75-85.
  • Matheson EC, Thomas H, Case M, Blair H, Jackson RK, Masic D, Veal G, Halsey C, Newell DR, Vormoor J, Irving JAE. . Haematologica 2019, 104(9), 1804-1811.
  • Adamson PC, Veal GJ, Womer RB, Meany HJ, Bernhardt MB, Frazier AL, Balis FM. . Pediatric Blood and Cancer 2019, 66(6), e27672.
  • Danilenko M, Hodgson K, Stones R, Husain A, Zangarini M, Veal G, Rajan N. . British Journal of Dermatology 2019, 180(4), 937-938.
  • Uitrakul S, Hutton C, Veal GJ, Jamieson D. . European Journal of Clinical Investigation 2019, 49(7), e13115.
  • Yogev O, Almeida GS, Barker KT, George SL, Kwok C, Campbell J, Zarowiecki M, Kleftogiannis D, Smith LM, Hallsworth A, Berry P, Möcklinghoff T, Webber HT, Danielson LS, Buttery B, Calton EA, da Costa BM, Poon E, Jamin Y, Lise S, Veal GJ, Sebire N, Robinson SP, Anderson J, Chesler L. . Cancer Research 2019, 79(20), 5382-5393.
  • Thomas F, Veal GJ, El Balkhi S, Lafont T, Picard N, Brugieres L, Chatelut E, Piguet C. . Cancer Chemotherapy and Pharmacology 2018, 82(2), 361-365.
  • Kim HY, Veal GJ, Zhou F, Boddy AV. . European Journal of Clinical Pharmacology 2018, 74(12), 1575-1584.
  • Martinez-Soria N, McKenzie L, Draper J, Ptasinska A, Issa H, Potluri S, Blair HJ, Pickin A, Isa A, Chin PS, Tirtakusuma R, Coleman D, Nakjang S, Assi S, Forster V, Reza M, Law E, Berry P, Mueller D, Elder A, Bomken SN, Pal D, Allan JM, Veal GJ, Cockerill PN, Wichmann C, Vormoor J, Lacaud G, Bonifer C, Heidenreich O. . Cancer Cell 2018, 34(4), 626-642.e8.
  • Fischer-Huchzermeyer S, Chikobava L, Stahn V, Zangarini M, Berry P, Veal GJ, Senner V, Mautner VF, Harder A. . BMC Research Notes 2018, 11(1), 520.
  • Danilenko M, Stamp E, Stocken DD, Husain A, Zangarini M, Cranston A, Stones R, Sinclair N, Hodgson K, Bowett SA, Roblin D, Traversa S, Plummer R, Veal G, Langtry JAA, Ashworth A, Burn J, Rajan N. . JAMA Dermatology 2018, 154(8), 913-921.
  • Brock PR, Maibach R, Childs M, Rajput K, Roebuck D, Sullivan MJ, Laithier V, Ronghe M, Dall'Igna P, Hiyama E, Brichard B, Skeen J, Mateos ME, Capra M, Rangaswami AA, Ansari M, Rechnitzer C, Veal GJ, Covezzoli A, Brugières L, Perilongo G, Czauderna P, Morland B, Neuwelt EA. . New England Journal of Medicine 2018, 378(25), 2376-2385.
  • White-Koning M, Osborne C, Paci A, Boddy AV, Chatelut E, Veal GJ. . European Journal of Cancer 2018, 91, 56-67.
  • Veal GJ, Malik S, Lupo M, MacFarlane S, Lepola P, Costello M, Ceci A, Boué C, Lecour L, Otto A, Rastegari M, Berry P. . BMJ Paediatrics Open 2017, 1(1), 1-7.
  • Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, Rothermundt C, Wood Z, Benson C, Ali N, Marple M, Veal G, Jamieson D, Küver K, Tirabosco R, Forsyth S, Nash S, Dehbi H, Beare S. . Lancet Oncology 2017, 18(10), 1397-1410.
  • Zangarini M, Rajan N, Danilenko M, Berry P, Traversa S, Veal GJ. . Bioanalysis 2017, 9(3), 279-288.
  • Zangarini M, Berry P, Sludden J, Raynaud FI, Banerji U, Jones P, Edwards D, Veal GJ. . Bioanalysis 2017, 9(13), 1001-1010.
  • Vormoor B, Veal GJ, Griffin MJ, Boddy AV, Irving J, Minto L, Case M, Banerji U, Swales KE, Tall JR, Moore AS, Toguchi M, Acton G, Dyer K, Schwab C, Harrison CJ, Grainger JD, Lancaster D, Kearns P, Hargrave D, Vormoor J. . Pediatric Blood & Cancer 2017, 64(6), e26351 1-4.
  • Gota V, Chinnaswamy G, Vora T, Rath S, Yadav A, Gurjar M, Veal G, Kurkure P. . Cancer Chemotherapy and Pharmacology 2016, 78(4), 763-768.
  • Siebert N, Eger C, Seidel D, Jüttner M, Zumpe M, Wegner D, Kietz S, Ehlert K, Veal GJ, Siegmund W, Weiss M, Loibner H, Ladenstein R, Lode HN. . mAbs 2016, 8(3), 604-616.
  • Jackson RK, Irving JAE, Veal GJ. . British Journal of Haematology 2016, 173(1), 13-24.
  • Errington J, Malik G, Evans J, Baston J, Parry A, Price L, Johnstone H, Peters S, Oram V, Howe K, Whiteley E, Tunnacliffe J, Veal GJ. . Pediatric Blood & Cancer 2016, 63(7), 1193-1197.
  • Walsh C, Bonner JJ, Johnson TN, Neuhoff S, Ghazaly EA, Gribben JG, Boddy AV, Veal GJ. . British Journal of Clinical Pharmacology 2016, 81(5), 989-998.
  • Veal GJ, Cole M, Chinnaswamy G, Sludden J, Jamieson D, Errington J, Malik G, Hill CR, Chamberlain T, Boddy AV. . European Journal of Cancer 2016, 55, 56–64.
  • Veal GJ, Errington J, Sastry J, Chisholm J, Brock P, Morgenstern D, Pritchard-Jones K, Chowdhury T. . Cancer Chemotherapy and Pharmacology 2016, 77(4), 685-692.
  • Veal GJ, Errington J, Hayden J, Hobin D, Murphy D, Dommett RM, Tweddle DA, Jenkinson H, Picton S. . European Journal of Cancer 2015, 51(14), 2022-2030.
  • Avan A, Adema AD, Hoebe EK, Huijts CM, Avan A, Veal GJ, Ruijtenbeek R, Wosikowski K, Peters GJ. . Current Drug Targets 2014, 15(14), 1312-1321.
  • Hill CR, Cole M, Errington J, Malik G, Boddy AV, Veal GJ. . Clinical Pharmacokinetics 2014, 53(8), 741-751.
  • Hill CR, Jamieson D, Thomas HD, Brown CDA, Boddy AV, Veal GJ. . Biochemical Pharmacology 2013, 85(1), 29-37.
  • Veal GJ, Errington J, Rowbotham SE, Illingworth NA, Malik G, Cole M, Daly AK, Pearson ADJ, Boddy AV. . Clinical Cancer Research 2013, 19(2), 469-479.
  • Jarvis IWH, Meczes EL, Thomas HD, Edmondson RJ, Veal GJ, Boddy AV, Ottley CJ, Pearson DG, Tilby MJ. . Biochemical Pharmacology 2012, 83(1), 69-77.
  • Armstrong JL, Martin S, Illingworth NA, Jamieson D, Neilson A, Lovat PE, Redfern CPF, Veal GJ. . Oncology Reports 2012, 27(1), 293-298.
  • Gomaa MS, Lim AST, Wilson-Lau SC, Watts AM, Illingworth NA, Bridgens CE, Veal GJ, Redfern CPF, Brancale A, Armstrong JL, Simons C. . Bioorganic & Medicinal Chemistry 2012, 20(20), 6080-6088.
  • Daly AK, Veal GJ, Jamieson D, Coulthard S. . Pharmacogenomics 2012, 13(12), 1333-1338.
  • Gomaa MS, Bridgens CE, Illingworth NA, Veal GJ, Redfern CPF, Brancale A, Armstrong JL, Simons C. . Bioorganic & Medicinal Chemistry 2012, 20(14), 4201-4207.
  • Orienti I, Zuccari G, Falconi M, Teti G, Illingworth NA, Veal GJ. . Nanomedicine: Nanotechnology, Biology and Medicine 2012, 8(6), 880-890.
  • Veal GJ, Boddy AV. . Seminars in Fetal and Neonatal Medicine 2012, 17(4), 243-248.
  • Veal GJ, Nguyen L, Paci A, Riggi M, Amiel M, Valteau-Couanet D, Brock P, Ladenstein R, Vassal G. . European Journal of Cancer 2012, 48(16), 3063-3072.
  • Gomaa MS, Bridgens CE, Veal GJ, Redfern CPF, Brancale A, Armstrong JL, Simons C. . Journal of Medicinal Chemistry 2011, 54(19), 6803-6811.
  • Gomaa MS, Bridgens CE, Aboraia AS, Veal GJ, Redfern CPF, Brancale A, Armstrong JL, Simons C. . Journal of Medicinal Chemistry 2011, 54(8), 2778-2791.
  • Chinnaswamy G, Errington J, Foot A, Boddy AV, Veal GJ, Cole M. . European Journal of Cancer 2011, 47(10), 1556-1563.
  • Illingworth NA, Boddy AV, Daly AK, Veal GJ. . British Journal of Pharmacology 2011, 162(4), 989-999.
  • Rowbotham SE, Illingworth NA, Daly AK, Veal GJ, Boddy AV. . Drug Metabolism and Disposition 2010, 38(7), 1211-1217.
  • Rowbotham SE, Boddy AV, Redfern CPF, Veal GJ, Daly AK. . Drug Metabolism and Disposition 2010, 38(8), 1261-1266.
  • Armstrong JL, Flockhart R, Veal GJ, Lovat PE, Redfern CPF. . Journal of Biological Chemistry 2010, 285(9), 6091-6100.
  • Veal GJ, Cole M, Errington J, Pearson ADJ, Gerrard M, Whyman G, Ellershaw C, Boddy AV. . Cancer Chemotherapy and Pharmacology 2010, 65(6), 1057-1066.
  • Giraud B, Hebert G, Deroussent A, Veal GJ, Vassal G, Paci A. . Expert Opinion on Drug Metabolism and Toxicology 2010, 6(8), 919-938.
  • Israels T, Damen CWN, Cole M, van Geloven N, Boddy AV, Caron HN, Beijnen JH, Molyneux EM, Veal GJ. . European Journal of Cancer 2010, 46(10), 1841-1847.
  • Veal GJ, Hartford CM, Stewart CF. . Journal of Clinical Oncology 2010, 28(32), 4790-4799.
  • Nannizi S, Veal GJ, Giovannetti E, Mey V, Ricciardi S, Ottley CJ, Del Tacca M, Danesi R. . Cancer Chemotherapy and Pharmacology 2010, 66(3), 547-558.
  • Picton S, Keeble J, Holden V, Errington J, Boddy AV, Veal GJ. . Cancer Chemotherapy and Pharmacology 2009, 63(4), 749-752.
  • Rhodin M, Anderson B, Peters A, Coulthard M, Wilkins B, Cole M, Chatelut E, Grubb A, Veal GJ, Keir M, Holford N. . Pediatric Nephrology 2009, 24, 67-76.
  • Mondick JT, Gibiansky L, Gastonguay MR, Skolnik JM, Cole M, Veal GJ, Boddy AV, Adamson PC, Barrett JS. . Journal of Clinical Pharmacology 2008, 48(1), 35-42.
  • Gomaa MS, Armstrong JL, Bobillon B, Veal GJ, Brancale A, Redfern CPF, Simons C. . Bioorganic and Medicinal Chemistry 2008, 16(17), 8301-8313.
  • Chinnaswamy G, Cole M, Boddy AV, Keir M, Price L, Parry AP, English M, Veal GJ. . British Journal of Cancer 2008, 99(6), 894-899.
  • Armstrong, J.L., Veal, G.J., Redfern, C.P.F., Lovat, P.E. . Apoptosis 2007, 12(3), 613-622.
  • Veal, G. J., Rowbotham, S., Boddy, A. V. . Therapie 2007, 62(2), 91-93.
  • Veal GJ, Cole M, Errington J, Pearson ADJ, Foot A, Whyman G, Boddy AV. . British Journal of Cancer 2007, 96(3), 424-431.
  • Armstrong J, Taylor GA, Thomas HD, Boddy AV, Redfern C, Veal GJ. . British Journal of Cancer 2007, 96(11), 1675-1683.
  • Veal GJ, Errington J, Tilby MJ, Pearson ADJ, Foot A, McDowell H, Ellershaw C, Pizer B, Nowell G, Pearson D, Boddy AV. . British Journal of Cancer 2007, 96(5), 725-731.
  • Cole M, Price L, Parry AP, Picton S, Waters F, Marshall S, Goran C, Parnham A, Wastell H, Reid M, Pearson ADJ, Boddy AV, Veal GJ. . Pediatric Blood and Cancer 2007, 48(7), 687-695.
  • Cole M, Boddy AV, Kearns P, Teh KH, Price L, Parry A, Pearson ADJ, Veal GJ. . Pediatric Blood and Cancer 2006, 46(7), 723-727.
  • Jounaidi Y, Chen C-S, Veal GJ, Waxman DJ. . Molecular Cancer Therapeutics 2006, 5(3), 541-555.
  • Veal GJ, Errington J, Thomas HD, Boddy AV, Lowis S. . Cancer Chemotherapy and Pharmacology 2006, 58(3), 415-417.
  • Veal, G. J., Cole, M., Errington, J., Parry, A. P., Hale, J. P., Pearson, A. D. J., Howe, K., Chisholm, J., Beane, C., Brennan, B., Waters, F., Glaser, A., Hemsworth, S., McDowell, H., Wright, Y., Pritchard-Jones, K., Pinkerton, R., Jenner, G., Nicholson, J., Elsworth, A., Boddy, A. V. . Clinical Cancer Research 2005, 11(16), 5893-5899.
  • Armstrong, J., Ruiz, M., Boddy, A. V., Redfern, C., Pearson, A. D. J., Veal, G. J. . British Journal of Cancer 2005, 92(4), 696-704.
  • Veal, G. J., English, M., Grundy, R., Shakespeare, C., Glaser, A., Waters, F., Holden, V., O'Meara, A., Michalski, A., Howe, K., Cole, S., Boddy, A. V. . Cancer Chemotherapy and Pharmacology 2004, 54(4), 295-300.
  • Cole M, Price L, Parry AP, Keir M, Pearson ADJ, Boddy A V, Veal GJ. . British Journal of Cancer 2004, 90(1), 60-64.
  • Cooper, B., Veal, G.J., Radivoyevitch, T., Tilby, M., Meyerson, H., Lazarus, H., Koc, O., Creger, R., Pearson, G., Nowell, G., Gosky, D., Ingalls, S., Hoppel, C., Gerson, S. . Clinical Cancer Research 2004, 10(20), 6830-6839.
  • Veal, G. J., Errington, J., Sludden, J., Griffin, M. J., Price, L., Parry, A. P., Hale, J. P., Pearson, A. D. J., Boddy, A. V. . Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2003, 795(2), 237-243.
  • Rana B, Veal GJ, Pearson ADJ, Redfern CPF. . Journal of Cellular Biochemistry 2002, 86(1), 67-78.
  • Veal, G. J., Errington, J., Redfern, C., Pearson, A. D. J., Boddy, A. V. . Biochemical Pharmacology 2002, 63(2), 207-215.
  • Veal, G. J., Errington, J., Redfern, C. P. F., Pearson, A. D. J., Boddy, A. V. . British Journal of Cancer 2001, 85(1), 93-97.
  • Veal, G. J., Dias, C., Price, L., Parry, A. P., Errington, J., Hale, J. P., Pearson, A. D. J., Boddy, A. V., Newell, D. R., Tilby, M. J. . Clinical Cancer Research 2001, 7(8), 2205-2212.
  • Veal, G. J., Griffin, M., Price, E., Parry, A. P., Dick, G., Little, M., Yule, S., Morland, B., Estlin, E., Hale, J. P., Pearson, A. D. J., Welbank, H., Boddy, A. V. . British Journal of Cancer 2001, 84(8), 1029-1035.

• Letters

  • Veal GJ. . Journal of Clinical Oncology 2025, 43(28), 3137-3138.
  • Geurten C, Errington J, Barnett S, Patel H, Noor S, Saraff V, Veal GJ, Gatz SA. . Pediatric Blood and Cancer 2023, 70(9), e30430.
  • Veal GJ, Boddy AV. . Journal of Clinical Oncology 2012, 30(27), 3424.

• Reviews

  • Berezowska M, Hayden IS, Brandon AM, Zats A, Patel M, Barnett S, Ogungbenro K, Veal GJ, Taylor A, Suthar J. . British Journal of Clinical Pharmacology 2025, 91(4), 1064-1079.
  • Lovell AL, Makamo N, Veal GJ, Bernhardt MB, Barr R, Gala RM, Gordon E, Ladas EJ, Prasad M, Rogers PC, Schoeman J, Slone JS, Viani K, Tissing WJE, Huibers MHW. . British Journal of Cancer 2025, 133, 275-285.
  • Streefkerk N, Masroor A, Geller JI, van Grotel M, Ansari M, Bouffet E, Bleyer A, Fresnau B, Sullivan M, Huitema ADR, Hoetink AE, Kogner P, Maibach R, O Neill AF, Papadakis V, Rajput KM, Veal GJ, Brock PR, Meijer JM, van den Heuvel-Eibrink MM. . EJC Paediatric Oncology 2025, 5, 100211.
  • Meijer AJM, Diepstraten FA, Ansari M, Bouffet E, Bleyer A, Fresneau B, Geller JI, Huitema ADR, Kogner P, Maibach R, O'Neill AF, Papadakis V, Rajput KM, Veal GJ, Sullivan M, van den Heuvel-Eibrink MM, Brock PR. . Journal of Clinical Oncology 2024, 42(18), 2219-2232.
  • Rahman R, Janowski M, Killick-Cole CL, Singleton WGB, Campbell E, Walczak P, Khatua S, Faltings L, Symons M, Schneider JR, Kwan K, Boockvar JA, Gill SS, Oliveira JM, Beccaria K, Carpentier A, Canney M, Pearl M, Veal GJ, Meijer L, Walker DA. . Cancers 2023, 15(3), 857.
  • Barnett S, Holden V, Campbell-Hewson Q, Veal GJ. . Frontiers in Oncology 2022, 11, 815040.
  • Nijstad AL, Barnett S, Lalmohamed A, Bérénos IM, Parke E, Carruthers V, Tweddle DA, Kong J, Zwaan CM, Huitema ADR, Veal GJ. . European Journal of Cancer 2022, 164, 137-154.
  • Barnett S, Kong J, Makin G, Veal GJ. . British Journal of Clinical Pharmacology 2021, 87(2), 256-262.
  • Veal GJ, Amankwatia EB, Paludetto M-N, Möcklinghoff T, Thomson F, André N, Ciccolini J, Chatelut E. . Therapeutic Drug Monitoring 2019, 41(2), 142-159.
  • Bardin C, Veal G, Paci A, Chatelut E, Astier A, Leveque D, Widmer N, Beijnen J. . European Journal of Cancer 2014, 50(12), 2005-2009.
  • Widmer N, Bardin C, Chatelut E, Paci A, Beijnen J, Leveque D, Veal G, Astier A. . European Journal of Cancer 2014, 50(12), 2020-2036.
  • Paci A, Veal G, Bardin C, Leveque D, Widmer N, Beijnen J, Astier A, Chatelut E. . European Journal of Cancer 2014, 50(12), 2010-2019.
  • Veal GJ. . Clinical Investigation 2014, 4(11), 1005-1011.
  • Armstrong, J.L., Redfern, C.P.F., Veal, G.J. . Biochemical Pharmacology 2005, 69(9), 1299-1306.
  • Estlin E, Veal G. . Cancer Treatment Reviews 2003, 29(4), 253-273.
  • Veal, G. J., Coulthard, S., Boddy, A. V. . Investigational New Drugs 2003, 21(2), 149-156.